Rein Therapeutics Files 8-K
Ticker: RNTX · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1420565
| Field | Detail |
|---|---|
| Company | Rein Therapeutics, Inc. (RNTX) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing, amendment
TL;DR
Rein Therapeutics filed an 8-K on 7/11 for events on 7/8, including corporate changes and financials. Formerly Aileron Therapeutics.
AI Summary
Rein Therapeutics, Inc. filed an 8-K on July 11, 2025, reporting events that occurred on July 8, 2025. The filing indicates amendments to its Articles of Incorporation or Bylaws, other events, and financial statements/exhibits. The company was formerly known as Aileron Therapeutics, Inc., with a name change effective March 29, 2024.
Why It Matters
This 8-K filing signals potential corporate changes or significant events for Rein Therapeutics, Inc., which could impact its strategic direction and investor outlook.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting corporate events and financial statements, not indicating immediate financial distress or significant operational shifts.
Key Players & Entities
- Rein Therapeutics, Inc. (company) — Registrant
- July 8, 2025 (date) — Earliest event reported
- July 11, 2025 (date) — Date of report
- Aileron Therapeutics, Inc. (company) — Former company name
- March 29, 2024 (date) — Date of name change
FAQ
What specific amendments were made to Rein Therapeutics' Articles of Incorporation or Bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text.
What are the 'Other Events' reported by Rein Therapeutics on July 8, 2025?
The filing states 'Other Events' occurred on July 8, 2025, but the nature of these events is not detailed in the provided excerpt.
What financial statements and exhibits are included with this 8-K filing?
The filing mentions 'Financial Statements and Exhibits' are included, but the specific contents are not listed in the provided text.
When did Rein Therapeutics, Inc. officially change its name from Aileron Therapeutics, Inc.?
The name change from Aileron Therapeutics, Inc. to Rein Therapeutics, Inc. was effective on March 29, 2024.
What is the principal executive office address for Rein Therapeutics, Inc.?
The principal executive offices are located at 12407 N. Mopac Expy., Suite 250 #390, Austin, Texas 78758.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 regarding Rein Therapeutics, Inc. (RNTX).